Association of corticosteroid (CS) exposure with treatment failure in patients (pts) with advanced melanoma treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Le, H. M. L. [1 ]
Pozas Perez, J. [2 ]
San Roman Gil, M. V. [2 ]
Serrano Domingo, J. J. [2 ]
Larkin, J. [1 ]
机构：
[1] NHS Fdn Trust, Med Dept, Royal Marsden Hosp, London, England
[2] Ramon y Cajal Univ Hosp, Med Oncol Dept, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1158P
引用
收藏
页码：S691 / S691
页数：1
相关论文
共 50 条
  • [41] Early incidence of immune-related adverse events (irAEs) predicts efficacy in patients (pts) with solid tumors treated with immune-checkpoint inhibitors (ICIs).
    Morehouse, Chris
    Abdullah, Shaad Essa
    Gao, Chen
    Dar, Mohammed M.
    Ranade, Koustubh
    Higgs, Brandon W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Exploring the Frequency and Risk Factors of Hyperprogressive Disease in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
    Acar, Caner
    Yuksel, Haydar Cagatay
    Sahin, Gokhan
    Acar, Fatma Pinar
    Karaca, Burcak
    CURRENT ONCOLOGY, 2024, 31 (10) : 6343 - 6355
  • [43] EPIDEMIOLOGY AND RISK FACTORS FOR THE DEVELOPMENT OF RHEUMATIC TOXICITIES IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Bruce, Alana
    Menzies, Alexander
    Long, Georgina
    Adams, Cameron
    Joshua, Fredrick
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 29 - 30
  • [44] EFFECT OF CANCER STAGE ON ADVERSE KIDNEY OUTCOMES IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Wang, Qiyu
    Strohbehn, Ian
    Strohbehn, Samuel
    Lee, Meghan
    Seethapathy, Harish
    Hanna, Paul
    Fadden, Riley
    Reynolds, Kerry
    Sullivan, Ryan
    Zhao, Sophia
    Boland, Genevieve
    Sise, Meghan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I252 - I253
  • [45] Vitiligo is correlated with clinical benefits in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors (ICI).
    Reinas, Gaston Martin
    Muino, Marcelo
    Abal, Mariana
    Gerardi, Carlos Garcia
    Tognelli, Flavio
    Deza, Ernesto Gil
    Gonzalez, Cesar
    Gonzalez, Liliana D.
    Nunell, Marcelo Andres
    Ordonez, Alba Marin
    Morgenfeld, Eduardo L.
    Rivarola, Edgardo G. J.
    Gercovich, Felipe G.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
    Cass, S. H.
    Tobin, J. W. D.
    Seo, Y. D.
    Gener-Ricos, G.
    Keung, E. Z.
    Burton, E. M.
    Davies, M. A.
    Mcquade, J. L.
    Lazar, A. J.
    Mason, R.
    Millward, M.
    Sandhu, S.
    Khoo, C.
    Warburton, L.
    Guerra, V.
    Haydon, A.
    Dearden, H.
    Menzies, A. M.
    Carlino, M. S.
    Smith, J. L.
    Mollee, P.
    Burgess, M.
    Mapp, S.
    Keane, C.
    Atkinson, V.
    Parikh, S. A.
    Markovic, S. N.
    Ding, W.
    Call, T. G.
    Hampel, P. J.
    Long, G., V
    Wargo, J. A.
    Ferrajoli, A.
    ANNALS OF ONCOLOGY, 2023, 34 (09) : 796 - 805
  • [47] CHOLESTATIC LIVER INJURY AND LDH LEVELS ARE ASSOCIATED WITH POOR RESPONSE TO CORTICOSTEROID THERAPY IN PATIENTS WITH MELANOMA AND LIVER TOXICITY RELATED TO IMMUNE CHECKPOINT INHIBITORS (ICIS)
    Patricia Llovet, Laura
    Pesantez, David
    Carrera, Cristina
    Arance, Ana
    Carlota Londono, Maria
    HEPATOLOGY, 2019, 70 : 1374A - 1375A
  • [48] Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non-small cell lung cancer (NSCLC)
    Pasello, Giulia
    Fabricio, Aline Sueli Coelho
    Del Bianco, Paola
    Favaretto, Adolfo
    Salizzato, Valentina
    Piccin, Luisa
    Zustovich, Fable
    De Rossi, Costanza
    Pigozzo, Jacopo
    Fabozzi, Alessio
    Benetti, Beatrice
    Fasiolo, Laura Tiozzo
    Bonanno, Laura
    Guarneri, Valentina
    De Salvo, Gian Luca
    Palleschi, Dario
    Gion, Massimo
    Chiarion-Sileni, Vanna
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Association of polybromo-associated BAF (PBAF) complex mutations with overall survival (OS) in cancer patients (pts) treated with checkpoint inhibitors (ICIs).
    Abou Alaiwi, Sarah
    Nassar, Amin
    El Bakouny, Ziad
    Berchuck, Jacob E.
    Nuzzo, Pier
    Flippot, Ronan
    Flaifel, Abdallah
    Steinharter, John A.
    Baca, Sylvan
    Margolis, Claire
    Vokes, Natalie
    Du, Heng
    Shukla, Sachet A.
    Braun, David A.
    Signoretti, Sabina
    Sonpavde, Guru
    Kwiatkowski, David J.
    Van Allen, Eliezer Mendel
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors
    Kevin Tyan
    Joanna Baginska
    Martha Brainard
    Anita Giobbie-Hurder
    Mariano Severgnini
    Michael Manos
    Rizwan Haq
    Elizabeth I. Buchbinder
    Patrick A. Ott
    F. Stephen Hodi
    Osama E. Rahma
    Cancer Immunology, Immunotherapy, 2021, 70 : 2209 - 2221
12345